» Articles » PMID: 31864341

Focused Screening Reveals Functional Effects of MicroRNAs Differentially Expressed in Colorectal Cancer

Abstract

Background: Colorectal cancer (CRC) is still a leading cause of death worldwide. Recent studies have pointed to an important role of microRNAs in carcinogenesis. Several microRNAs are described as aberrantly expressed in CRC tissues and in the serum of patients. However, functional outcomes of microRNA aberrant expression still need to be explored at the cellular level. Here, we aimed to investigate the effects of microRNAs aberrantly expressed in CRC samples in the proliferation and cell death of a CRC cell line.

Methods: We transfected 31 microRNA mimics into HCT116 cells. Total number of live propidium iodide negative (PI-) and dead (PI+) cells were measured 4 days post-transfection by using a high content screening (HCS) approach. HCS was further used to evaluate apoptosis (via Annexin V and PI staining), and to discern between intrinsic and extrinsic apoptotic pathways, by detecting cleaved Caspase 9 and 8, respectively. To reveal mRNA targets and potentially involved mechanisms, we performed microarray gene expression and functional pathway enrichment analysis. Quantitative PCR and western blot were used to validate potential mRNA targets.

Results: Twenty microRNAs altered the proliferation of HCT116 cells in comparison to control. miR-22-3p, miR-24-3p, and miR-101-3p significantly repressed cell proliferation and induced cell death. Interestingly, all anti-proliferative microRNAs in our study had been previously described as poorly expressed in the CRC samples. Predicted miR-101-3p targets that were also downregulated by in our microarray were enriched for genes associated with Wnt and cancer pathways, including MCL-1, a member of the BCL-2 family, involved in apoptosis. Interestingly, miR-101-3p preferentially downregulated the long anti-apoptotic MCL-1 L isoform, and reduced cell survival specifically by activating the intrinsic apoptosis pathway. Moreover, miR-101-3p also downregulated IL6ST, STAT3A/B, and MYC mRNA levels, genes associated with stemness properties of CRC cells.

Conclusions: microRNAs upregulated in CRC tend to induce proliferation in vitro, whereas microRNAs poorly expressed in CRC halt proliferation and induce cell death. We provide novel evidence linking preferential inhibition of the anti-apoptotic MCL-1 L isoform by miR-101-3p and consequent activation of the intrinsic apoptotic pathway as potential mechanisms for its antitumoral activity, likely due to the inhibition of the IL-6/JAK/STAT signaling pathway.

Citing Articles

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers.

Vizkeleti L, Spisak S Cells. 2023; 12(13).

PMID: 37443779 PMC: 10341379. DOI: 10.3390/cells12131745.


Dynamic alternative polyadenylation during iPSC differentiation into cardiomyocytes.

Yang Y, Wu X, Yang W, Jin W, Wang D, Yang J Comput Struct Biotechnol J. 2022; 20:5859-5869.

PMID: 36382196 PMC: 9636549. DOI: 10.1016/j.csbj.2022.10.025.


lncRNA TRPM2-AS Promotes Colorectal Cancer Progression by Regulating miR-22-3p and FSTL1.

Gao Y, Liu B, Liu X, Gao Y, Shan J, Li Y J Oncol. 2022; 2022:1366511.

PMID: 36268275 PMC: 9578789. DOI: 10.1155/2022/1366511.


Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network.

Long F, Tian L, Chai Z, Li J, Tang Y, Liu M Front Med (Lausanne). 2022; 9:881788.

PMID: 36237545 PMC: 9551196. DOI: 10.3389/fmed.2022.881788.


The identification of miRNA and mRNA expression profiles associated with pediatric atypical teratoid/rhabdoid tumor.

Xu X, Yuan H, Pan J, Chen W, Chen C, Li Y BMC Cancer. 2022; 22(1):499.

PMID: 35524230 PMC: 9074338. DOI: 10.1186/s12885-022-09549-6.


References
1.
Zhang G, Zhou T, Liu Z, Tian H, Xia S . Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma. Mol Clin Oncol. 2014; 1(2):379-384. PMC: 3915707. DOI: 10.3892/mco.2013.61. View

2.
Mooi J, Luk I, Mariadason J . Cell Line Models of Molecular Subtypes of Colorectal Cancer. Methods Mol Biol. 2018; 1765:3-26. DOI: 10.1007/978-1-4939-7765-9_1. View

3.
Bonfrate L, Altomare D, Di Lena M, Travaglio E, Rotelli M, De Luca A . MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment. J Gastrointestin Liver Dis. 2013; 22(3):311-20. View

4.
Lin S, Ying S . Mechanism and Method for Generating Tumor-Free iPS Cells Using Intronic MicroRNA miR-302 Induction. Methods Mol Biol. 2018; 1733:265-282. DOI: 10.1007/978-1-4939-7601-0_22. View

5.
Katona B, Liu Y, Ma A, Jin J, Hua X . EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells. Cancer Biol Ther. 2014; 15(12):1677-87. PMC: 4622469. DOI: 10.4161/15384047.2014.972776. View